Overview

A Phase I Study to Evaluate the Oral Absorption of Nepadutant in Infants

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the gastrointestinal absorption of nepadutant after single dose as oral solution (and the effect of age on its oral absorption) in infants. Oral absorption is evaluated through the drug recovery in urine.
Phase:
Phase 1
Details
Lead Sponsor:
Menarini Group
Treatments:
MEN 11420